000293741 000__ 03184cam\a22004334a\4500
000293741 001__ 293741
000293741 005__ 20210513110844.0
000293741 008__ 040922s2005\\\\nyua\\\\\b\\\\001\0\engs\
000293741 010__ $$a  2004022295
000293741 015__ $$aGBA491210
000293741 0167_ $$a013069507$$2Uk
000293741 0167_ $$a101241480$$2DNLM
000293741 020__ $$a0814408451
000293741 0291_ $$aNLM$$b101241480
000293741 035__ $$a(OCoLC)ocm56591961
000293741 035__ $$a293741
000293741 040__ $$aDLC$$cDLC$$dUKM$$dIAC$$dWAU$$dOCL$$dNLM$$dBAKER$$dIXA$$dISE
000293741 042__ $$apcc
000293741 043__ $$an-us---
000293741 049__ $$aISEA
000293741 05000 $$aRA418.5.M4$$bD49 2005
000293741 08200 $$a610/.28$$222
000293741 1001_ $$aDeyo, Richard A.
000293741 24510 $$aHope or hype :$$bthe obsession with medical advances and the high cost of false promises /$$cRichard A. Deyo, Donald L. Patrick.
000293741 260__ $$aNew York :$$bAMACOM, American Management Association,$$cc2005.
000293741 300__ $$axvi, 335 p. :$$bill. ;$$c24 cm.
000293741 504__ $$aIncludes bibliographical references (p. [291]-326) and index.
000293741 5051_ $$aCan there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical  advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
000293741 650_0 $$aMedical innovations$$zUnited States$$xEvaluation.
000293741 650_0 $$aMedical technology$$zUnited States$$xEvaluation.
000293741 650_0 $$aMedical care$$xTechnological innovations$$zUnited States$$xEvaluation.
000293741 650_0 $$aMedical care$$zUnited States$$xEvaluation.
000293741 650_0 $$aMedical innovations$$xEconomic aspects$$zUnited States.
000293741 650_0 $$aMedical technology$$zUnited States$$xCost effectiveness.
000293741 650_0 $$aMedical care$$xTechnological innovations$$zUnited States$$xCost effectiveness.
000293741 650_0 $$aMedical care, Cost of$$zUnited States.
000293741 7001_ $$aPatrick, Donald L.
000293741 85200 $$bgen$$hRA418.5.M4$$iD49$$i2005
000293741 85641 $$3Table of contents$$uhttp://www.loc.gov/catdir/toc/ecip051/2004022295.html
000293741 909CO $$ooai:library.usi.edu:293741$$pGLOBAL_SET
000293741 980__ $$aBIB
000293741 980__ $$aBOOK
000293741 994__ $$aC0$$bISE